KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Healthpeak Properties (DOC) Investment in Debt & Equity (2016 - 2018)

Healthpeak Properties has reported Investment in Debt & Equity over the past 10 years, most recently at $713.8 million for Q4 2018.

  • Quarterly Investment in Debt & Equity changed 0.07% to $713.8 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $713.8 million through Dec 2018, changed 0.07% year-over-year, with the annual reading at $713.8 million for FY2018, 0.07% changed from the prior year.
  • Investment in Debt & Equity was $713.8 million for Q4 2018 at Healthpeak Properties, roughly flat from $714.7 million in the prior quarter.
  • Over five years, Investment in Debt & Equity peaked at $7.3 billion in Q4 2014 and troughed at $711.8 million in Q2 2017.
  • The 5-year median for Investment in Debt & Equity is $5.5 billion (2015), against an average of $3.9 billion.
  • Year-over-year, Investment in Debt & Equity skyrocketed 1858.14% in 2014 and then tumbled 87.85% in 2017.
  • A 5-year view of Investment in Debt & Equity shows it stood at $7.3 billion in 2014, then fell by 28.57% to $5.2 billion in 2015, then crashed by 85.53% to $752.6 million in 2016, then dropped by 5.08% to $714.4 million in 2017, then dropped by 0.07% to $713.8 million in 2018.
  • Per Business Quant, the three most recent readings for DOC's Investment in Debt & Equity are $713.8 million (Q4 2018), $714.7 million (Q3 2018), and $712.6 million (Q2 2018).